Lyon Joseph Douglas Insider Trading -- Recent SEC Form 4 Transactions
Lyon Joseph Douglas (CIK 1817838) reported 54 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-10-05). Recent activity: Sell CORT (810 shares), Buy CORT (810 shares), Buy CORT (3,357 shares), Buy CORT (5,833 shares), Sell CORT (4,446 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-05 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 810 | $93,473 |
| 2026-10-05 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 810 | $10,984 |
| 2026-10-05 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 3,357 | $45,521 |
| 2026-10-05 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 5,833 | $112,344 |
| 2026-10-05 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 4,446 | $514,389 |
| 2026-10-05 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 4,744 | $552,869 |
| 2026-09-16 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 2,596 | $29,465 |
| 2026-09-16 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 7,404 | $100,398 |
| 2026-09-16 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 7,812 | $885,261 |
| 2026-09-16 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 2,188 | $249,686 |
| 2026-09-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 72 | $8,163 |
| 2026-09-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 130 | $0 |
| 2026-09-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 130 | $14,739 |
| 2026-08-05 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 1,540 | $175,806 |
| 2026-06-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 537 | $0 |
| 2026-06-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 269 | $18,948 |
| 2026-06-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 537 | $37,826 |
| 2026-05-29 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 5,000 | $325,000 |
| 2026-03-04 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 398 | $14,316 |
| 2026-03-04 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 398 | $0 |
| 2026-03-04 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 89 | $3,201 |
| 2025-12-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 178 | $0 |
| 2025-12-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 5,000 | $67,800 |
| 2025-12-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 5,000 | $397,650 |
| 2025-12-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 178 | $14,201 |
Source: SEC Form 4 filings · as of 2026-10-05